Trinity biotech announces a $45 million strategic investment and partnership with the mico group of south korea

Dublin, ireland, april 11, 2022 (globe newswire) -- trinity biotech plc (nasdaq: trib), a leading global diagnostic company (“trinity biotech” or the “company”), today announced a $45 million strategic investment and partnership with mico ltd (“mico”). mico, a kosdaq-listed and korea-based company, is engaged in the biomedical business through its affiliate mico biomed, in addition to providing cutting-edge technology driven solutions in the semi-conductor and green energy sectors.
TRIB Ratings Summary
TRIB Quant Ranking